GlassScriptPhysician profile
Manuel J Gonzalez
NPI 1710061239
$23,286.65
in general payments reported to CMS, 2019-2025
34 companies · $13K in 2025
The $13K reported for 2025 was more than what 92% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,468 · 2020: $1,186 · 2021: $2,225 · 2022: $1,936 · 2023: $784 · 2024: $1,741 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $3,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,570.31 |
| Food and Beverage | $3,901.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,680.34 | 2021-2025 | Endurant Iis, Venaseal |
| Bolton Medical INC | $2,933.99 | 2019-2024 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Endologix LLC | $1,119.59 | 2019-2023 | Afx2 Bifurcated Endograft System |
| Angiodynamics, INC. | $1,028.78 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Kerecis Limited | $1,009.13 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| W. L. Gore & Associates, INC. | $848.01 | 2020-2022 | |
| Penumbra, INC. | $436.33 | 2019-2025 | Penumbra System, Indigo System, Ruby Coil |
| Medtronic Vascular, INC. | $436.13 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $342.40 | 2020-2021 | |
| Mimedx Group, INC. | $322.36 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $222.10 | 2019-2020 | |
| Atricure, INC. | $182.68 | 2022 | |
| Melinta Therapeutics, LLC | $176.48 | 2019-2024 | Kimyrsa |
| Alexion Pharmaceuticals, INC. | $160.02 | 2021-2022 | |
| Sonex Health, INC. | $149.45 | 2021-2023 | Sx-One Microknife |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $134.43 | 2021-2022 | |
| Tactile Systems Technology INC | $126.23 | 2020-2023 | Flexitouch Plus, Entre Plus |
| Kci USA, INC. | $126.16 | 2022-2023 | 3m Cavilon |
| Medline Industries LP | $124.34 | 2021 | |
| Philips North America LLC | $117.67 | 2019-2025 | Azurion 7 M20 |
| Reapplix INC. | $115.14 | 2024 | 3c Patch Kit - Box |
| Mallinckrodt Hospital Products INC. | $74.77 | 2023 | Terlivaz |
| Urgo Medical North America, LLC | $72.52 | 2022 | |
| Convatec INC. | $63.43 | 2021-2024 | |
| Smith+Nephew, INC. | $50.45 | 2019-2021 | |
| Amniox Medical, INC. | $45.46 | 2020 | |
| Organogenesis INC. | $38.59 | 2025 | Apligraf |
| Bayer Healthcare Pharmaceuticals INC. | $33.28 | 2022 | |
| Abbvie INC. | $28.46 | 2021-2023 | |
| Baxter Healthcare | $20.88 | 2021 | |
| Shionogi INC | $18.79 | 2022 | |
| Biocompatibles, INC. | $17.44 | 2019 | |
| Boston Scientific Corporation | $15.64 | 2022 | |
| Glaxosmithkline, LLC. | $15.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.